DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer	Borderline Resectable Pancreatic Ductal Adenocarcinoma	Recruiting	Phase 1 / Phase 2	2026-10-05		NCT07705919

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
Ohio State University Comprehensive Cancer Center	112

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Ohio State University Comprehensive Cancer Center	Columbus	United States	548

Clinical trials